- Taspoglutide
-
- $0.00 / 1kg
-
2022-10-13
- CAS:275371-94-3
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1Ton
- Taspoglutide
-
- $15.00 / 1KG
-
2021-07-13
- CAS:275371-94-3
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
| | Taspoglutide Basic information |
| Product Name: | Taspoglutide | | Synonyms: | Taspoglutide Acetate;taspoglutide;BIM-51077;ITM-077;ITM-077;R-1583;BIM-51077;R-1583;7-36-Glucagon-like peptide I (human), 8-(2-methylalanine)-35-(2-methylalanine)-36-L-argininamide-;aspoglutide | | CAS: | 275371-94-3 | | MF: | C152H232N40O45 | | MW: | 3339.71 | | EINECS: | | | Product Categories: | | | Mol File: | 275371-94-3.mol |  |
| | Taspoglutide Chemical Properties |
| density | 1.46 | | storage temp. | -20°C | | solubility | DMSO : ≥ 28 mg/mL (8.38 mM) | | form | lyophilized powder | | color | white to beige | | Sequence | H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Aib-Arg-NH2 |
| | Taspoglutide Usage And Synthesis |
| General Description | Taspoglutide with -methylalanine in greatly retard degradation by DPP-IV and neutral endopeptidase24.11, respectively (see preceding discussion for exenatide).The phase III trials, which commenced in 2008, arebeing conducted with a zinc-based preparation, prolongingthe duration in a manner similar to zinc-containing insulinpreparations, so that once-weekly injections of 20 to 30 mgwill be possible. |
| | Taspoglutide Preparation Products And Raw materials |
|